Skip to main content
Top
Published in: Journal of Endocrinological Investigation 10/2004

01-11-2004 | Original Article

Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas

Authors: M. Filopanti, MD, E. Ballarè, A. G. Lania, S. Bondioni, U. Verga, M. Locatelli, L. M. Zavanone, M. Losa, S. Gelmini, A. Peri, C. Orlando, P. Beck-Peccoz, A. Spada

Published in: Journal of Endocrinological Investigation | Issue 10/2004

Login to get access
Metadata
Title
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas
Authors
M. Filopanti, MD
E. Ballarè
A. G. Lania
S. Bondioni
U. Verga
M. Locatelli
L. M. Zavanone
M. Losa
S. Gelmini
A. Peri
C. Orlando
P. Beck-Peccoz
A. Spada
Publication date
01-11-2004
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 10/2004
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/BF03347536

Other articles of this Issue 10/2004

Journal of Endocrinological Investigation 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine